Coach vs. Kors: Bat...
Health Care: Drugs
Athersys Inc. (ATHX: OTC)
$1.41 -0.07 | -4.73%
06/01/12 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.41 |
| 52 Week High | 2.90 |
| 52 Week Low | 1.00 |
| Avg. Daily Vol. (Mil) | 0.11 |
| Beta (3 year) | 1.33 |
| Share Related Items | |
| Mkt Cap (Mil) | 41.45 |
| Shares Out (Mil) | 29.40 |
| Float (Mil) | 27.45 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.80 |
| Current Ratio | 2.90 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.10 |
| Price/Book | 5.17 |
| Price/Cash Flow | -3.00 |
| Per Share Data | |
| Earnings | -0.59 |
| Sales | 0.34 |
| Book Value | 0.27 |
| Cash Flow | -0.47 |
| Business Summary | |
|---|---|
| Athersys Inc. is engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. | |
| General Information | |
| 3201 Carnegie Avenue
Cleveland, OH 44115-2634 |
|
| www.athersys.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 48 | |
| CEO: Dr. Gil Van Bokkelen | |
| Short Interest | |
| Current Month (Mil) | 0.08 |
| Previous Month (Mil) | 0.10 |
| Short Interest Ratio (Days) | 0.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -76.90 |
| Return on Investments | -176.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ATHX
- Portfolio NameUser Type
- Contributor10 Cheap Biotech Stocks Tha...
- UserAlfa
- Contributor9 Health Care Stocks With 1...
- Contributor10 Pharma Stocks With 100% ...
- Contributor10 Biotech Stocks Expected ...
- UserFuture Speculation
- User©SUPRATRADE HOT STOCKS (...
- UserBesV Portfolio 1
- Userdawnf Portfolio 1
- UserMangar's picks
Latest ATHX Headlines from TheStreet
- Aastrom Raises Cash To Fund Pivotal Trial 03.09.12 | 12:03 pm
- Athersys Reports Fourth Quarter And 2010 Annual Results 03.14.11 | 04:03 pm
- Athersys Announces Initiation Of Patient Enrollment For Phase II Clinical Trial In Inflammatory Bowel Disease 03.14.11 | 07:03 am
- Athersys To Host Fourth Quarter Financial Results Call 02.18.11 | 07:02 am
- Researchers From UTHealth And Athersys Present Preclinical Data Illustrating Potential Benefits Of MultiStem(R) For Treating Stroke 02.10.11 | 07:02 am
- Athersys To Present At 13th Annual BIO CEO & Investor Conference 02.08.11 | 02:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Athersys Announces Registered Direct Offering Of $13.1 Million 01.28.11 | 09:01 am
- Researchers From Case Western Reserve And Athersys Publish Landmark Study Showing Regenerative Benefit Of MultiStem Therapy After Spinal Cord Injury 01.19.11 | 07:01 am
- Athersys Announces Completion Of Patient Enrollment For Single Dose Arm Of Phase I Study Of MultiStem(R) For Hematopoietic Stem Cell Transplant Support 01.06.11 | 07:01 am
Press Releases for ATHX
- Athersys, Inc. - Retail Investor Conferences.com Presentation Now Available Online - PR Newswire 01.24.11 | 12:01 pm
- RTI Biologics And Athersys Announce Collaboration In The Orthopedic Market - Business Wire 09.13.10 | 07:09 am
Partner Headlines for ATHX
- Follow the Analyst Leader: New Stock Coverage to Watch - Wall St. Cheat Sheet 05.31.12 | 04:05 am
- Microcap Movers for Friday December 2 , 2011 - Benzinga 12.02.11 | 05:12 pm
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 09.23.11 | 09:09 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.31.11 | 09:08 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 08.26.11 | 09:08 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 08.12.11 | 09:08 am
- Athersys Q2 Loss Is Slight Improvement Over Previous Year - Seeking Alpha 08.11.11 | 09:08 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.10.11 | 09:05 am
- 4 Biotech Companies That Could Be Buyout Targets - Seeking Alpha 04.05.11 | 08:04 am
